Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Arrowhead Pharma (ARWR)

Arrowhead Pharma (ARWR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,574,393
  • Shares Outstanding, K 102,757
  • Annual Sales, $ 87,990 K
  • Annual Income, $ -84,550 K
  • 60-Month Beta 1.61
  • Price/Sales 75.58
  • Price/Cash Flow N/A
  • Price/Book 13.88
Trade ARWR with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 1.02
  • Number of Estimates 5
  • High Estimate 2.78
  • Low Estimate -0.13
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +3,500.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.05 +16.49%
on 11/25/20
72.50 -9.94%
on 11/19/20
+0.95 (+1.48%)
since 11/04/20
3-Month
32.86 +98.69%
on 09/11/20
72.50 -9.94%
on 11/19/20
+29.25 (+81.16%)
since 09/04/20
52-Week
19.51 +234.65%
on 03/18/20
72.50 -9.94%
on 11/19/20
-1.17 (-1.76%)
since 12/04/19

Most Recent Stories

More News
Look for Shares of Arrowhead Pharma to Potentially Pullback after Yesterday's 1.89% Rise

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $63.19 to a high of $65.33. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high...

ARWR : 65.29 (+2.05%)
NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, today announced the appointment...

NBSE : 8.30 (+3.11%)
ARWR : 65.29 (+2.05%)
Arrowhead Pharmaceuticals to Participate in Upcoming Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

ARWR : 65.29 (+2.05%)
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the collaboration and license agreement between Arrowhead and Takeda Pharmaceutical Company Limited announced on October 8, 2020, has...

TKPYY : 16.5900 (-0.90%)
ARWR : 65.29 (+2.05%)
29.4% Return Seen to Date on SmarTrend Arrowhead Pharma Call (ARWR)

SmarTrend identified an Uptrend for Arrowhead Pharma (NASDAQ:ARWR) on September 16th, 2020 at $46.59. In approximately 2 months, Arrowhead Pharma has returned 29.41% as of today's recent price of $60.29....

ARWR : 65.29 (+2.05%)
Arrowhead Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 23, 2020 / Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on November...

ARWR : 65.29 (+2.05%)
Arrowhead Pharmaceuticals Reports Fiscal 2020 Year End Results

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal year ended September 30, 2020. The company is hosting a conference call at 4:30 p.m. EST to discuss results....

ARWR : 65.29 (+2.05%)
Watch for Arrowhead Pharma to Potentially Rebound After Falling 1.48% Yesterday

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $66.58 to a high of $69.15. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of...

ARWR : 65.29 (+2.05%)
Look for Shares of Arrowhead Pharma to Potentially Pullback after Yesterday's 5.51% Rise

Arrowhead Pharma (NASDAQ:ARWR) traded in a range yesterday that spanned from a low of $69.00 to a high of $72.50. Yesterday, the shares gained 5.5%, which took the trading range above the 3-day high...

ARWR : 65.29 (+2.05%)
Arrowhead Pharma Up 52.2% Since SmarTrend Uptrend Call (ARWR)

SmarTrend identified an Uptrend for Arrowhead Pharma (NASDAQ:ARWR) on September 16th, 2020 at $46.59. In approximately 2 months, Arrowhead Pharma has returned 52.17% as of today's recent price of $70.89....

ARWR : 65.29 (+2.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes....

See More

Key Turning Points

2nd Resistance Point 67.17
1st Resistance Point 66.23
Last Price 65.29
1st Support Level 63.69
2nd Support Level 62.09

See More

52-Week High 72.50
Last Price 65.29
Fibonacci 61.8% 52.26
Fibonacci 50% 46.01
Fibonacci 38.2% 39.75
52-Week Low 19.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar